Guardant Health Note 11/1 (Principal)
|
5.3 |
$157M |
|
250M |
0.63 |
Nanostring Technologies Note 2.625% 3/0 (Principal)
|
4.0 |
$118M |
|
146M |
0.81 |
Novocure Note 11/0 (Principal)
|
3.9 |
$118M |
|
132M |
0.89 |
Exact Sciences Corp Note 0.375% 3/0 (Principal)
|
3.7 |
$110M |
|
139M |
0.79 |
Alphatec Hldgs Note 0.750% 8/0 (Principal)
|
3.5 |
$103M |
|
112M |
0.92 |
Nevro Corp Note 2.750% 4/0 (Principal)
|
3.4 |
$100M |
|
109M |
0.92 |
Glaukos
(GKOS)
|
2.4 |
$73M |
|
1.7M |
43.68 |
Iveric Bio
|
2.4 |
$72M |
|
3.3M |
21.41 |
Biogen Idec
(BIIB)
|
2.3 |
$70M |
|
253k |
276.92 |
Vaxcyte
(PCVX)
|
2.2 |
$65M |
|
1.4M |
47.95 |
Natera
(NTRA)
|
2.2 |
$65M |
|
1.6M |
40.17 |
Bridgebio Pharma Note 2.500% 3/1 (Principal)
|
2.1 |
$64M |
|
142M |
0.45 |
Crinetics Pharmaceuticals In
(CRNX)
|
2.1 |
$64M |
|
3.5M |
18.30 |
Xenon Pharmaceuticals
(XENE)
|
2.0 |
$61M |
|
1.5M |
39.43 |
Intuitive Surgical Com New
(ISRG)
|
2.0 |
$59M |
|
223k |
265.35 |
Deciphera Pharmaceuticals
(DCPH)
|
1.8 |
$54M |
|
3.3M |
16.39 |
Karyopharm Therapeutics Note 3.000%10/1 (Principal)
|
1.7 |
$49M |
|
66M |
0.75 |
Ionis Pharmaceuticals Note 4/0 (Principal)
|
1.6 |
$49M |
|
53M |
0.93 |
Nevro
(NVRO)
|
1.6 |
$47M |
|
1.2M |
39.60 |
Travere Therapeutics Note 2.500% 9/1 (Principal)
|
1.6 |
$47M |
|
51M |
0.92 |
Irhythm Technologies
(IRTC)
|
1.6 |
$47M |
|
498k |
93.67 |
Align Technology
(ALGN)
|
1.6 |
$46M |
|
220k |
210.90 |
Outset Med
(OM)
|
1.5 |
$44M |
|
1.7M |
25.82 |
Amyris Note 1.500%11/1 (Principal)
|
1.4 |
$43M |
|
138M |
0.31 |
Orthopediatrics Corp.
(KIDS)
|
1.4 |
$42M |
|
1.0M |
39.73 |
Exact Sciences Corp Note 0.375% 3/1 (Principal)
|
1.3 |
$40M |
|
48M |
0.83 |
Aclaris Therapeutics
(ACRS)
|
1.3 |
$38M |
|
2.4M |
15.75 |
Insmed Note 1.750% 1/1 (Principal)
|
1.3 |
$38M |
|
400M |
0.09 |
Neogenomics Note 1.250% 5/0 (Principal)
|
1.2 |
$37M |
|
43M |
0.85 |
Penumbra
(PEN)
|
1.2 |
$36M |
|
163k |
222.46 |
Amgen
(AMGN)
|
1.2 |
$34M |
|
131k |
262.64 |
Bellus Health Com New
|
1.1 |
$34M |
|
4.1M |
8.22 |
Ionis Pharmaceuticals Note 0.125%12/1 (Principal)
|
1.1 |
$33M |
|
37M |
0.91 |
Legend Biotech Corp Sponsored Ads
(LEGN)
|
1.1 |
$33M |
|
658k |
49.92 |
Nuvasive Note 0.375% 3/1 (Principal)
|
1.1 |
$32M |
|
37M |
0.88 |
Neogenomics Note 0.250% 1/1 (Principal)
|
1.1 |
$32M |
|
49M |
0.66 |
Syndax Pharmaceuticals
(SNDX)
|
1.1 |
$32M |
|
1.2M |
25.45 |
Merus N V
(MRUS)
|
1.0 |
$31M |
|
2.0M |
15.47 |
Travere Therapeutics
(TVTX)
|
1.0 |
$31M |
|
1.5M |
21.03 |
Travere Therapeutics Note 2.250% 3/0 (Principal)
|
1.0 |
$29M |
|
31M |
0.92 |
Krystal Biotech
(KRYS)
|
1.0 |
$28M |
|
358k |
79.22 |
Hillevax
(HLVX)
|
0.9 |
$27M |
|
1.6M |
16.73 |
Day One Biopharmaceuticals I
(DAWN)
|
0.9 |
$27M |
|
1.2M |
21.52 |
Dice Therapeutics
|
0.9 |
$26M |
|
839k |
31.20 |
Quidel Corp
(QDEL)
|
0.9 |
$26M |
|
300k |
85.67 |
Globus Med Cl A
(GMED)
|
0.9 |
$26M |
|
344k |
74.27 |
ACADIA Pharmaceuticals
(ACAD)
|
0.8 |
$24M |
|
1.5M |
15.92 |
Anaptysbio Inc Common
(ANAB)
|
0.8 |
$23M |
|
726k |
30.99 |
Silk Road Medical Inc Common
(SILK)
|
0.7 |
$22M |
|
417k |
52.85 |
Esperion Therapeutics
(ESPR)
|
0.7 |
$21M |
|
3.4M |
6.23 |
Biomarin Pharmaceutical Note 1.250% 5/1 (Principal)
|
0.7 |
$21M |
|
19M |
1.08 |
Apellis Pharmaceuticals
(APLS)
|
0.7 |
$20M |
|
390k |
51.71 |
Rapt Therapeutics
(RAPT)
|
0.7 |
$20M |
|
1.0M |
19.80 |
Mirati Therapeutics
|
0.6 |
$19M |
|
414k |
45.31 |
Transmedics Group
(TMDX)
|
0.6 |
$19M |
|
303k |
61.72 |
Argenx Se Sponsored Adr
(ARGX)
|
0.6 |
$19M |
|
49k |
378.83 |
Dbv Technologies S A Sponsored Adr
(DBVT)
|
0.6 |
$19M |
|
12M |
1.53 |
Sarepta Therapeutics
(SRPT)
|
0.6 |
$18M |
|
140k |
129.58 |
Replimune Group
(REPL)
|
0.6 |
$18M |
|
662k |
27.20 |
Steris Shs Usd
(STE)
|
0.6 |
$18M |
|
96k |
184.69 |
Edwards Lifesciences
(EW)
|
0.6 |
$18M |
|
235k |
74.61 |
ImmunoGen
|
0.6 |
$17M |
|
3.5M |
4.96 |
Cooper Cos Com New
|
0.6 |
$17M |
|
52k |
330.67 |
Invitae Corp Note 2.000% 9/0 (Principal)
|
0.6 |
$17M |
|
22M |
0.79 |
Nuvasive Note 1.000% 6/0 (Principal)
|
0.5 |
$16M |
|
17M |
0.98 |
Bridgebio Pharma Note 2.250% 2/0 (Principal)
|
0.5 |
$16M |
|
42M |
0.38 |
Enanta Pharmaceuticals
(ENTA)
|
0.5 |
$15M |
|
326k |
46.52 |
Pulmonx Corp
(LUNG)
|
0.5 |
$14M |
|
1.6M |
8.43 |
Mersana Therapeutics
(MRSN)
|
0.4 |
$11M |
|
1.9M |
5.86 |
Immatics SHS
(IMTX)
|
0.4 |
$11M |
|
1.3M |
8.71 |
Protagonist Therapeutics
(PTGX)
|
0.3 |
$10M |
|
928k |
10.91 |
Biomarin Pharmaceutical Note 0.599% 8/0 (Principal)
|
0.3 |
$9.6M |
|
9.0M |
1.06 |
Miragen Therapeutics
(VRDN)
|
0.3 |
$9.2M |
|
313k |
29.21 |
Nkarta
(NKTX)
|
0.3 |
$9.1M |
|
1.5M |
5.99 |
Compass Therapeutics
(CMPX)
|
0.3 |
$9.1M |
|
1.8M |
5.03 |
Dyne Therapeutics
(DYN)
|
0.3 |
$8.7M |
|
753k |
11.59 |
Insmed Note 0.750% 6/0 (Principal)
|
0.3 |
$8.3M |
|
10M |
0.83 |
Nuvation Bio Com Cl A
(NUVB)
|
0.3 |
$7.9M |
|
4.1M |
1.92 |
Allakos
(ALLK)
|
0.3 |
$7.7M |
|
920k |
8.42 |
Alector
(ALEC)
|
0.2 |
$6.7M |
|
725k |
9.23 |
Kodiak Sciences
(KOD)
|
0.2 |
$6.5M |
|
914k |
7.16 |
Supernus Pharmaceuticals Note 0.625% 4/0 (Principal)
|
0.2 |
$6.4M |
|
6.5M |
0.99 |
Fusion Pharmaceuticals
(FUSN)
|
0.2 |
$6.3M |
|
2.0M |
3.15 |
Milestone Pharmaceuticals
(MIST)
|
0.2 |
$4.6M |
|
1.2M |
3.96 |
Moonlake Immunotherapeutics Class A Ord
(MLTX)
|
0.1 |
$4.0M |
|
381k |
10.50 |
Alx Oncology Hldgs
(ALXO)
|
0.1 |
$2.9M |
|
258k |
11.27 |
Nektar Therapeutics
(NKTR)
|
0.0 |
$1.4M |
|
620k |
2.26 |
Iteos Therapeutics
(ITOS)
|
0.0 |
$1.4M |
|
72k |
19.53 |